42.23  0.5 (1.2%)		01-16 16:00
Open: 41.73 High: 43.385 Volume: 15,461		Pre. Close: 41.73 Low: 41.73 Market Cap: 138(M)

Short term
Mid term
Targets	6-month :	55.36	1-year :	64.66
Resists	First :	47.4	Second :	55.36
Pivot price	40.34
Supports	First :	40.7	Second :	36.56
MAs	MA(5) :	41.72	MA(20) :	40.52
	MA(100) :	36.05	MA(250) :	41.71
MACD	MACD :	0.8	Signal :	0.8
%K %D	K(14,3) :	71.7	D(3) :	60.6
RSI	RSI(14): 56.7
52-week	High :	70.26	Low :	23.46

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PDEX ] has closed below upper band by 19.3%. Bollinger Bands are 42.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	43.44 - 43.6	43.6 - 43.77
Low:	41.3 - 41.49	41.49 - 41.69
Close:	41.91 - 42.21	42.21 - 42.52

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Sat, 17 Jan 2026
Pro-Dex: A Niche Surgical Tools Microcap Trading At A Discount (NASDAQ:PDEX) - Seeking Alpha

Sat, 10 Jan 2026
We Think Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt With Ease - simplywall.st

Thu, 08 Jan 2026
Pro-Dex Valuation Is Attractive Despite Customer Risk (NASDAQ:PDEX) - Seeking Alpha

Fri, 19 Dec 2025
Pro-Dex, Inc. Announces Contract Extension With Largest Customer - FinancialContent

Mon, 01 Dec 2025
Long Cast Advisers’ Updates on Pro-Dex (PDEX) - Yahoo Finance

Thu, 30 Oct 2025
Pro-Dex Delivers Strong Growth With Revenue And Profit Jump - Finimize

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	3 (M)
Shares Float	2 (M)
Held by Insiders	36 (%)
Held by Institutions	31.8 (%)
Shares Short	212 (K)
Shares Short P.Month	211 (K)

EPS	3.31
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	12.72
Profit Margin	15.9 %
Operating Margin	16.7 %
Return on Assets (ttm)	11.3 %
Return on Equity (ttm)	30.9 %
Qtrly Rev. Growth	24.3 %
Gross Profit (p.s.)	6.05
Sales Per Share	21.54
EBITDA (p.s.)	3.69
Qtrly Earnings Growth	86.6 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	-2 (M)

PE Ratio	12.71
PEG Ratio	0
Price to Book value	3.31
Price to Sales	1.96
Price to Cash Flow	-109.27

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.